# US 2016/0353734 A1 · Hypersensitive response elicitor peptides and use thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2016/0353734 A1
- Document ID: US20160353734A1
- Status: Published application
- Kind: A1
- Application number: 15/244,707
- Filed: 2016-08-23
- Published: 2016-12-08
- Earliest claimed: 2014-10-01
- Assignees: Plant Health Care, Inc.
- Applicants: Plant Health Care, Inc.
- Inventors: Zhongmin Wei; Gregory A. Zornetzer
- Web page: https://patentgrep.com/patent/US20160353734A1

## CPC

- C12N 15/8279: {for biotic stress resistance, pathogen resistance, disease resistance}
- A01N 25/02: containing liquids as carriers, diluents or solvents
- A01N 25/12: Powders or granules (A01N25/26 takes precedence)
- A01N 37/22: the nitrogen atom being directly attached to an aromatic ring system, e.g. anilides
- A01N 37/46: N-acyl derivatives
- A01N 43/36: five-membered rings
- A01N 43/54: 1,3-Diazines; Hydrogenated 1,3-diazines
- A01N 43/90: having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system
- A01N 47/44: Guanidine; Derivatives thereof
- A01N 51/00: Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds having the sequences of atoms O—N—S, X—O—S, N—N—S, O—N—N or O-halogen, regardless of the number of bonds each atom has and with no atom of these sequences forming part of a heterocyclic ring
- A01N 63/00: Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates (containing compounds of determined constitution A01N27/00 - A01N59/00; unicellular algae A01N65/03)
- A01N 63/10: Animals; Substances produced thereby or obtained therefrom
- A01N 63/50: Isolated enzymes; Isolated proteins (peptides A01N37/46)
- A61P 31/12: Antivirals
- C07K 7/08: having 12 to 20 amino acids (gastrins C07K14/595; somatostatins C07K14/655; melanotropins C07K14/68)
- C07K 14/001: {by chemical synthesis}
- C07K 14/195: from bacteria
- C07K 14/24: from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
- C07K 14/27: Erwinia (G)
- C07K 14/415: from plants
- C12N 15/8283: {for virus resistance}
- C07K 2319/00: Fusion polypeptide
- C07K 2319/20: containing a tag with affinity for a non-protein ligand
- Y02A 40/22: Improving land use; Improving water use or availability; Controlling erosion
- Y02A 40/28: specially adapted for farming
- Y02P 60/40: Afforestation or reforestation
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- A01N: PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF (preservation of food or foodstuff A23); BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES (preparations for medical, dental or toiletry purposes which kill or prevent the growth or proliferation of unwanted organisms A61K); PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- Y02A: TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02P: CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS

## Abstract

Disclosed are hypersensitive-response eliciting peptides that exhibit improved solubility, stability, resistance to chemical degradation, or a combination of these properties. Use of these peptides or fusion polypeptides, or DNA constructs encoding the same, for modulating plant biochemical signaling, imparting disease resistance to plants, enhancing plant growth, imparting tolerance to biotic stress, imparting tolerance and resistance to abiotic stress, imparting desiccation resistance to cuttings removed from ornamental plants, imparting post-harvest disease or post-harvest desiccation resistance to a fruit or vegetable, or enhancing the longevity of fruit or vegetable ripeness are also disclosed.

## Claims

### Claim 1

An isolated peptide comprising the amino acid sequence of ITPDGQGGGQIGDNPLLKALLKLIA (SEQ ID NO: 90) or XLXX(L/M)LXLIXX(L/I/V/F/M)(L/IN/F/M)(SEQ ID NO: 26, P19 consensus), wherein
X at position 1 is optional and can be L, I, V, F, or M;
X at position 3 can be any amino acid, but preferably K, A, S, T, G, D, isoD, E, g-glutamate, Q, N, or R;
X at position 4 can be any amino acid, but preferably A, S, T, G, D, isoD, E, g-glutamate, Q, N, K, or R;
X at position 7 can be any amino acid, but preferably K, A, S, T, G, D, isoD, E, g-glutamate, Q, N, or R;
X at position 10 can be any amino acid, but preferably A, S, T, G, D, isoD, E, g-glutamate, Q, N, K, or R; and
X at position 11 can be any amino acid, but preferably R, A, S, T, G, D, isoD, E, g-glutamate, Q, N, or K.

### Claim 2 (depends on 1)

The isolated peptide according to claim 1, wherein the isolated peptide comprises one or more mutations, relative to a polypeptide having a corresponding wildtype amino acid sequence that consists of SEQ ID NO: 89, and the isolated peptide is either (i) more stable than the polypeptide of SEQ ID NO: 89 when dissolved in water or aqueous solution; or (ii) more resistant to chemical degradation than the polypeptide of SEQ ID NO: 89 when dissolved in an aqueous buffer solution containing a biocide.

### Claim 3 (depends on 1)

The isolated peptide according to claim 1, wherein the peptide comprises the amino acid sequence of one of SEQ ID NOS: 91, 168-173, and 226.

### Claim 4 (depends on 1)

The isolated peptide according to claim 1, wherein the peptide comprises the amino acid sequence of SEQ ID NOS: 90.

### Claim 5 (depends on 1)

The isolated peptide according to claim 1, wherein the peptide is between 20 and 50 amino acids in length.

### Claim 6 (depends on 1)

The isolated peptide according to claim 1, wherein the amino acid residue at position 1 of SEQ ID NO: 26 is present.

### Claim 7 (depends on 1)

The isolated peptide according to claim 1, wherein the peptide is at least 90% pure.

### Claim 8 (depends on 1)

The isolated peptide according to claim 1, wherein the peptide is a fusion polypeptide comprising a second amino acid sequence coupled via peptide bond to the amino acid sequence.

### Claim 9 (depends on 8)

The isolated peptide according to claim 8, wherein the second amino acid sequence includes a purification tag.

### Claim 10 (depends on 9)

The isolated peptide according to claim 9, wherein the second amino acid sequence further includes a cleavable linker sequence between the purification tag and the amino acid sequence.

### Claim 11 (depends on 8)

The isolated peptide according to claim 8, wherein the peptide is a fusion polypeptide comprising a first amino acid sequence for said peptide linked to a second amino acid sequence for said peptide.

### Claim 12 (depends on 1)

A fusion polypeptide comprising a plurality of amino acid sequences linked together in series, one of the plurality of amino acid sequences comprising the peptide according to claim 1.

### Claim 13 (depends on 1)

A composition comprising one or more peptides according to claim 1 and a carrier.

### Claim 14 (depends on 13)

The composition according to claim 13, wherein the composition is a clarified cell extract.

### Claim 15 (depends on 14)

The composition according to claim 14 further comprising an additive selected from the group consisting of fertilizer, herbicide, insecticide, fungicide, nematicide, a bactericidal agent, a biological inoculant, a plant regulator, and mixtures thereof.

### Claim 16 (depends on 15)

The composition according to claim 15, wherein the additive comprises either:
(i) clothianidin, a combination of clothianidin and Bacillus firmus, imidicloprid, or a combination of imidicloprid and Bacillus firmus; or
(ii) thiamethoxam; a combination of thiamethoxam, mefenoxam, and fludioxynil; a combination of thiamethoxam, mefenoxam, fludioxynil and azoxystrobin; a combination of thiamethoxam and abamectin; a combination of thiamethoxam, abamectin, and a Pasteuria nematicide; or a combination of thiamethoxam, mefenoxam, fludioxynil, azoxystrobin, thiabendazole, and abamectin; or
(iii) a biological inoculant comprising a Bradyrhizobium spp., a Bacillus spp., or a combination of a Bradyrhizobium spp. and a Bacillus spp.

### Claim 17 (depends on 13)

The composition according to claim 13, wherein the carrier is an aqueous carrier.

### Claim 18 (depends on 17)

The composition according to claim 17, wherein the aqueous carrier further comprises one or more of a biocidal agent, a protease inhibitor, a non-ionic surfactant, or a combination thereof.

### Claim 19 (depends on 13)

The composition according to claim 13, wherein the carrier is a solid carrier in particulate form.

### Claim 20 (depends on 19)

The composition according to claim 19, wherein the solid carrier is a dry powder.

### Claim 21 (depends on 1)

A method of imparting disease resistance to plants comprising:
applying an effective amount of an isolated peptide according to claim 1 to a plant or plant seed or the locus where the plant is growing or is expected to grow, wherein said applying is effective to impart disease resistance.

### Claim 22 (depends on 1)

A method of enhancing plant growth comprising:
applying an effective amount of an isolated peptide according to claim 1 to a plant or plant seed or the locus where the plant is growing or is expected to grow, wherein said applying is effective to enhance plant growth.

### Claim 23 (depends on 1)

A method of increasing a plant's tolerance to biotic stress comprising:
applying an effective amount of an isolated peptide according to claim 1 to a plant or plant seed or the locus where the plant is growing or is expected to grow, wherein said applying is effective to increase the plant's tolerance to biotic stress factors selected from the group consisting of insects, arachnids, nematodes, weeds, and combinations thereof.

### Claim 24 (depends on 1)

A method of increasing a plant's tolerance to abiotic stress comprising:
applying an effective amount of an isolated peptide according to claim 1 to a plant or plant seed or the locus where the plant is growing or is expected to grow, wherein said applying is effective to increase the plant's tolerance to abiotic stress factors selected from the group consisting of salt stress, water stress, ozone stress, heavy metal stress, cold stress, heat stress, nutritional stress, and combinations thereof.

### Claim 25 (depends on 1)

A DNA construct comprising a first nucleic acid molecule encoding an isolated peptide according to claim 1 and a promoter-effective nucleic acid molecule operably coupled to the first nucleic acid molecule.
